Treponema Pallidum Test Market
Treponema Pallidum Test Market Study Treponemal and Non-Treponemal Tests for Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, and Research from 2024 to 2034
Analysis of Treponema Pallidum Test Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Treponema Pallidum Test Market Outlook (2024 to 2034)
Worldwide revenue from the sales of Treponema pallidum test kits is expected to reach US$ 204.6 million in 2024. The global Treponema pallidum test market is analyzed to climb to a value of US$ 360 million by the end of 2034, expanding at a CAGR of 5.8%.
Treponemal tests, also known as confirmatory tests (FTA, TP-PA, and EIA), detect antibodies specific to syphilis. Following an acute infection, treponemal antibodies manifest sooner than non-treponemal antibodies. The antibodies found in these tests typically do not go away, even after a successful course of therapy. As a result, a reactive treponemal test can reveal a history of or present infection with syphilis.
Treponema pallidum, the pathogen responsible for syphilis, can be detected through two primary techniques: direct and indirect detection methods. These include tests conducted in the Venereal Disease Research Laboratory (VDRL), rapid plasma reagent (RPR) tests, unheated serum reagent (USR) tests, Treponema pallidum hemagglutination (TPHA) tests, Treponema passive particle agglutination (TPPA) tests, fluorescent treponemal antibody absorption (FTA-ABS) tests, enzyme immunoassay/enzyme-linked immunosorbent assay (EIA/ELISA) tests, and other diagnostic assays.
Key Market Growth Drivers
- Several new techniques and approaches have been developed over the years to culture T. pallidum in the laboratory and determine properties related to its metabolism and gene expression. This has made it possible to cultivate Treponema pallidum, the etiological agent.
- Demand for Treponema pallidum test kits is largely influenced by the rising prevalence of Treponema pallidum-caused syphilis. Need for testing is influenced by factors that affect prevalence rates, such as evolving sexual behaviors, gaps in public health initiatives, and inadequate access to healthcare.
- The need for testing is fueled by growing public awareness of sexually transmitted infections (STIs), particularly syphilis, and the value of early detection through screening programs. Higher testing rates are attributed to advocacy, education, and public health campaigns.
- Rapid diagnostic tests (RDTs), point-of-care testing (POCT), and molecular diagnostic techniques are enhancing the accuracy, speed, and accessibility of Treponema pallidum testing. These testing platforms and assay development innovations help improve the effectiveness of testing procedures.
- Supportive regulatory frameworks, as well as guidelines issued by health authorities and professional organizations, are critical for standardizing testing protocols, ensuring test quality, and encouraging the adoption of screening practices.
| Report Attribute | Detail |
|---|---|
| Treponema Pallidum Test Market Size (2024E) | US$ 204.6 Million |
| Forecasted Market Value (2034F) | US$ 360 Million |
| Global Market Growth Rate (2024 to 2034) | 5.8% CAGR |
| Latin America Market Share (2024E) | 13.9% |
| North America Market Share (2024E) | 23.5% |
| Revenue from Hospitals (2024E) | US$ 54.4 Million |
| Key Companies Profiled | AdvaCare Pharma, Beckman Coulter Inc.; Bio Rad Laboratories Inc.; Becton Dickinson and Co.; bioLytical Laboratories Inc.; Bloodworks Northwest; Calibre Scientific Inc.; Danaher Corp.; OK Biotech Co. Ltd.; DiaSorin SpA; Everlywell Inc.; Hologic Inc.; LetsGetChecked; Meril Life Sciences Pvt. Ltd.; F. Hoffmann La Roche Ltd. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Market Opportunities are Treponema Pallidum Test Manufacturers Leveraging?
“Increased Investments in Healthcare and Favorable Reimbursement for STI Testing”
Increased investments in the healthcare sector in developed and developing countries are improving access to testing services, including Treponema pallidum tests. The Treponema pallidum test market size is increasing steadily due to healthcare coverage and comprehensive reimbursement guidelines for STI testing. Increasing promiscuity, unprotected sex, and other high-risk sexual practices are examples of sexual behavior changes that result in a higher risk of syphilis and other STI transmission. The significance of routine testing among at-risk populations is highlighted by this trend.
Migration and international trips spread infectious diseases such as syphilis. People who may have been exposed to Treponema pallidum in various areas across the world need to be screened more and more as globalization grows. Emergence of drug-resistant strains of Treponema pallidum highlights the ongoing need for effective testing strategies to guide appropriate treatment decisions. Comprehensive testing methods that detect resistant strains are essential for managing syphilis outbreaks.
Which Challenges are Impeding the Adoption of Treponema Pallidum Tests?
“High Cost of Syphilis Diagnostic Testing and Frequent Modifications to Regulations”
One major factor impeding market growth is the high cost of the Treponema pallidum test. The cost-effectiveness of diagnostic tests is a crucial consideration. The cost of laboratory testing has increased due to the use of more advanced syphilis diagnostic test instruments, such as molecular tests and immunoassays.
Main cause of the high cost of such diagnostic tests is the costs associated with technology upgrades. Different diagnostic tests require new tests to be developed and frequent technological advancements. Furthermore, the costly upgradation of diagnostic equipment has been brought about by frequent modifications to regulations to guarantee interoperability between devices. For laboratories in the market that have average or low incomes, this upgrade process adds to their financial burden.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America holds a significant global market share of 23.5%. The region is well-served by a strong consumer base with considerable purchasing power, a thriving economy, and technological advancements. The rising urban population in Asia Pacific is driving up demand for Treponema pallidum test products and services. Syphilis testing is often integrated with HIV testing and care services, given the heightened prevalence of syphilis among individuals living with HIV. This integration promotes regular testing for both infections, leading to increased demand for Treponema pallidum tests.
Which Government Initiatives in the United States are Driving Market Growth?
“Focus on Enhancing Access to STI Testing Services and Availability of Home Testing Kits”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 37 Million |
| Growth Rate (2024 to 2034) | 5.8% CAGR |
| Projected Value (2034F) | US$ 64 Million |
The United States is set to hold 75% of the Treponema pallidum test market share in North America in 2024. Demand for Treponema pallidum tests is growing as a result of initiatives to enhance access to healthcare services, including STI testing. This covers the availability of home testing kits as well as testing in a variety of healthcare settings, including clinics, community health centers, and public health departments.
Stringent regulatory requirements, such as those established by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), for these tests are also a key Treponema pallidum test market trend. These rules are being followed by laboratories and healthcare facilities to ensure high-quality testing procedures.
How is the Market for Treponema Pallidum Test Evolving in Brazil?
“Market Benefitting from Integration of STI Testing into Primary Healthcare Services”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 13 Million |
| Growth Rate (2024 to 2034) | 6.6% CAGR |
| Projected Value (2034F) | US$ 26 Million |
Brazil is witnessing a resurgence in syphilis cases, particularly among certain population groups such as homosexuals, transgender people, and pregnant women. Given the high prevalence, it is crucial to conduct extensive testing to detect and treat cases as soon as possible. There has been a drive to make STI testing services more widely available throughout Brazil, especially in outlying and underdeveloped areas. This includes integrating STI testing into primary healthcare services and deploying rapid diagnostic tests (RDTs) and mobile testing units. All of these factors are contributing to the growth of the Treponema pallidum test market in the country.
Category-wise Insights
The global market for Treponema pallidum tests has been divided into two segments based on the type of tests: treponemal tests and non-treponemal tests, of which the latter is poised to hold 69.7% market share in 2024. The service providers for the global Treponema pallidum tests are hospitals, ambulatory surgical centers, specialty clinics, diagnostic laboratories, and academic & research institutes. Hospitals are set to account for a 26.6% market share and specialty clinics will hold a 23.4% market share in 2024.
What is the Advantage of Using Non-Treponemal Tests for Syphilis Identification?
“Exceptional Sensitivity of Non-Treponemal Assays in Detecting Primary and Secondary Syphilis”
| Attribute | Non-treponemal Tests |
|---|---|
| Segment Value (2024E) | US$ 142.5 Million |
| Growth Rate (2024 to 2034) | 5.7% CAGR |
| Projected Value (2034F) | US$ 248.6 Million |
Syphilis screening and diagnosis are frequently carried out using non-treponemal tests, such as the Venereal Disease Research Laboratory (VDRL) and Rapid Plasma Reagin (RPR) tests. These tests are appropriate for routine testing in healthcare settings and large-scale screening programs because they are quick, simple, and reasonably priced. They also produce fast results.
Non-treponemal assays exhibit exceptional sensitivity when it comes to identifying antibodies generated by the organism in reaction to a Treponema pallidum infection, especially in the initial phases of the illness. Even though treponemal tests can come back negative, this sensitivity makes it possible to identify both primary and secondary syphilis. In patients with syphilis, non-treponemal tests are also used to track the course of their illness and their response to treatment.
How Do Hospitals Ensure Accurate Interpretation of Test Results for Syphilis?
“Expertise of Physicians and Laboratory Medicine Specialists in Infectious Diseases”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 54.4 Million |
| Growth Rate (2024 to 2034) | 5.9% CAGR |
| Projected Value (2034F) | US$ 96.4 Million |
A wide range of medical services, including diagnostic testing for various conditions are typically provided by hospitals. They have staff members who have been trained to conduct specialized tests, such as syphilis tests, and laboratory facilities. Treponema pallidum testing is conveniently available to patients seeking medical care in hospitals, in addition to other medical services.
Hospitals frequently hire experts with knowledge of diagnosing and treating diseases such as syphilis, such as physicians who treat infectious diseases and laboratory medicine specialists. These experts can supervise the handling of syphilis cases, guarantee accurate interpretation of test results, and offer pertinent clinical advice.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the Treponema pallidum test industry are adopting the latest technology to improve the diagnostic testing facility. They are investing in research to make Treponema pallidum testing more accurate, quick, and easily accessible due to advancements in diagnostic technologies such as molecular diagnostic techniques, point-of-care testing (POCT), and rapid diagnostic tests (RDTs).
- In March 2024, Diagnostics Direct LLC, a leading provider of diagnostic testing solutions announced the formation of its distinguished Medical Advisory Board. The Board was formed to support the organization's efforts to improve syphilis diagnosis and care and to pinpoint areas that require particular focus. The company's commitment to increasing underprivileged groups' access to Syphilis Health Check, particularly for newborns and those looking for self-testing options, was highlighted by Norman Proulx, Co-Founder and CEO.
- In January 2024, the United States Food and Drug Administration (FDA) received a de novo authorization request from NowDiagnostics for its first-to-know over-the-counter (OTC) syphilis test in the United States. The First to Know test is an at-home lateral flow immunoassay that uses a fingerstick whole-blood sample to provide results within 10 minutes. The US$ 15 million series B funding round that NowDiagnostics is currently finishing up has been made public. In addition, the company has received a strategic investment from the Labcorp Venture Fund.
Fact.MR provides detailed information about the price points of key providers of Treponema pallidum tests positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.
Segmentation of Treponema Pallidum Test Market Research
-
By Test Type :
- Treponemal
- Non-treponemal
-
By Service Provider :
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Academic & Research Institutes
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. Test Type 6.2. Service Provider 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Test Type 7.1. Treponemal 7.2. Non-treponemal 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Service Provider 8.1. Hospitals 8.2. Specialty Clinics 8.3. Ambulatory Surgical Centers 8.4. Diagnostic Laboratories 8.5. Academic & Research Institutes 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. East Asia 9.6. South Asia & Pacific 9.7. Middle East & Africa 10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Sales Forecast 2024 to 2034 by Test Type, Service Provider, and Region for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. AdvaCare Pharma, Beckman Coulter Inc. 19.2. Bio Rad Laboratories Inc. 19.3. Becton Dickinson and Co. 19.4. bioLytical Laboratories Inc. 19.5. Bloodworks Northwest 19.6. Calibre Scientific Inc. 19.7. Danaher Corp. 19.8. OK Biotech Co. Ltd. 19.9. DiaSorin SpA 19.10. Everlywell Inc. 19.11. Hologic Inc. 19.12. LetsGetChecked 19.13. Meril Life Sciences Pvt. Ltd. 19.14. F. Hoffmann La Roche Ltd. 20. Assumptions and Acronyms Used 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 10: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 11: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 12: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 19: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 20: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 21: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 22: Latin America Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 23: Latin America Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 24: Latin America Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 28: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 29: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 30: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 31: Western Europe Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 32: Western Europe Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 33: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 34: Western Europe Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 35: Western Europe Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 36: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 37: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 38: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Eastern Europe Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 41: Eastern Europe Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 42: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 43: Eastern Europe Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 44: Eastern Europe Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 45: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 46: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 47: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 48: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 55: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 56: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 57: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 58: South Asia & Pacific Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 59: South Asia & Pacific Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 60: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 61: South Asia & Pacific Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 62: South Asia & Pacific Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 63: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
Table 64: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023
Table 65: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 66: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 67: MEA Market Value (US$ Mn) Analysis, by Test Type, 2019 to 2023
Table 68: MEA Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 69: MEA Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 70: MEA Market Value (US$ Mn) Analysis, by Service Provider, 2019 to 2023
Table 71: MEA Market Value (US$ Mn) Analysis, by Service Provider, 2024 to 2034
Table 72: MEA Market Value (US$ Mn) Opportunity Analysis, by Service Provider, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 14: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 15: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 16: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 17: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 18: North America Market Share Analysis by Country, 2024 & 2034
Figure 19: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 20: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 21: North America Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 27: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 28: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 29: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 30: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 31: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 32: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 33: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 34: Latin America Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 35: Latin America Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 36: Latin America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 37: Latin America Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 40: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 41: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 42: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 43: Western Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 44: Western Europe Market Share Analysis by Country, 2024 & 2034
Figure 45: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 46: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 47: Western Europe Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 48: Western Europe Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 49: Western Europe Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 50: Western Europe Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 51: Western Europe Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 52: Western Europe Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 53: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 54: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 55: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 56: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 57: Eastern Europe Market Share Analysis by Country, 2024 & 2034
Figure 58: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 59: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 60: Eastern Europe Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 61: Eastern Europe Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 62: Eastern Europe Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 63: Eastern Europe Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 64: Eastern Europe Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 65: Eastern Europe Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 66: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 67: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 68: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 69: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 70: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 71: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 72: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: East Asia Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 74: East Asia Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 75: East Asia Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 76: East Asia Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 77: East Asia Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 78: East Asia Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 79: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 80: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 81: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 82: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034
Figure 83: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034
Figure 84: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 85: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034
Figure 86: South Asia & Pacific Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 87: South Asia & Pacific Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 88: South Asia & Pacific Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 89: South Asia & Pacific Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 90: South Asia & Pacific Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 91: South Asia & Pacific Market Attractiveness Analysis by Service Provider, 2024 to 2034
Figure 92: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023
Figure 93: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 94: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034
Figure 95: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 96: MEA Market Share Analysis by Country, 2024 & 2034
Figure 97: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 98: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 99: MEA Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 100: MEA Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 101: MEA Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 102: MEA Market Share and BPS Analysis by Service Provider, 2024 & 2034
Figure 103: MEA Market Y-o-Y Growth Projections by Service Provider, 2024 to 2034
Figure 104: MEA Market Attractiveness Analysis by Service Provider, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the Treponema pallidum test market?
The global market for Treponema pallidum tests is expected to be valued at US$ 204.6 million in 2024.
What are the sales projections for Treponema pallidum tests over the decade?
The global market is forecasted to expand at 5.8% CAGR and reach US$ 360 million by the end of 2034.
Which country has a significant market for Treponema pallidum tests?
Revenue from Treponema pallidum tests in the United States is projected to reach US$ 37 million in 2024.
What are the projections for the market in Brazil?
Brazil is estimated to reach a market value of US$ 13 million in 2024.
Which service provider accounts for higher sales of the Treponema pallidum tests?
The hospitals segment is expected to reach a value of US$ 54.4 million in 2024.
What is the share of Canada in the North American market?
Canada accounts for a market share of 10.5% in North America in 2024.
Who are the leaders in the business of Treponema pallidum tests?
Calibre Scientific Inc., Danaher Corp., OK Biotech Co. Ltd., and DiaSorin SpA are some of the key players in the market.
Treponema Pallidum Test Market